Skip to content

Efficacy of the Thai-strains probiotics and plant extracts to relieve menopausal symptoms and to improve quality of life of Thai menopause women

Efficacy of the Thai-strains probiotics and plant extracts on genitourinary symptoms and microbiome, blood glucose and lipids, and health-related quality of life in Thai menopausal women

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240731003
Enrollment
120
Registered
2024-07-31
Start date
2024-03-26
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Natural or surgical menopause for 36 months - Menopause - Genitourinary Symptoms of Menopause (GSM) - Quality of life - Probiotics

Interventions

Probiotics (Thai Strains, Lactobacillus Paracasei, and Bifidobacterium Animalis, each at least 10 9 CFU/g) in a soft gel capsule Plant extracts containing Soy germ 100 mg, Dong Quai 80 mg, Chameleon p
Experimental Dietary Supplement,Placebo Comparator Dietary Supplement
Probiotics plus Plant Extracts,Placebo

Sponsors

Srinakharinwirot University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 40 - 60 who have been in menopause (either naturally or following surgery to remove the uterus and ovaries) for at least 36 months (3 years) since their last menstruation. 2. Meet at least one of the following criteria: have symptoms related to the genital system, urinary tract system, or sexual activity that occur after menopause, as assessed by the Menopause Rating Scale (MRS). They should not have received hormone replacement therapy before or have discontinued it for at least 6 months. 3. Breast examination shows no lumps and initial internal examination finds no lumps in the cervix, uterus, or ovaries. 4. No chronic diseases, including diabetes requiring medication, hypertension requiring medication, endocrine diseases like thyroid disorders, heart disease, liver disease, kidney disease, breast cancer, ovarian cancer, uterine cancer, or depression. 5. No history of allergy to soy or soy derivatives. 6. Willing to participate in the research project, including undergoing internal examinations, blood tests, laboratory tests, and ultrasound examinations, and able to attend follow-up appointments as scheduled.

Exclusion criteria

Exclusion criteria: 1. Volunteers who are treating a vaginal infection or urinary tract infection by taking antibiotics or who have recently stopped taking antibiotics for treating bacterial infections from other causes within the last 2 weeks. 2. Have a history of severe adverse effects from using hormone replacement therapy, any soy-based products, and extracts from Dong Quai, Chameleon plant, or rosehip. 3. Have a history of lumping the breast or an abnormal breast cancer screening result that has not been conclusively resolved. 4. Have a history of abnormal bleeding or irregular menstruation within the past 36 months. 5. Have a history of gastrointestinal symptoms, including gastritis, diarrhea, chronic constipation, or irritable bowel syndrome.

Design outcomes

Primary

MeasureTime frame
vaginal microbiome Day 0 and Day 84 Metagenomic 16S RNA sequencing to determine taxon diversity and abundance,Vaginal maturation index Day 0 and Day 84 Grades determined microscopically ,Fasting glucose level Day 0 and Day 84 Blood chemistry (g/dl) ,Lipid profile (LDL, HDL, TG, total cholesterol) Day 0 and Day 84 Blood chemistry ,Adverse effects Day 42 and Day 84 clinical review, history taking

Secondary

MeasureTime frame
Menopause rating scale Day 0, Day 42, Day 84 Standardized questionnaire,Menopause Specific Quality of Life (MEN-QOL) Day 0, Day 42, Day 84 Standardized questionnaire

Countries

Thailand

Contacts

Public ContactAmarin Narkwichean

Department of Obstetrics and Gynecology, Faculty of Medicine, Srinakharinwirot University

amarin@g.swu.ac.th006637395451

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026